MedPath

A mobile based multidisciplinary virtual clinic for patients with Heart Failure: A Controlled Randomised Trial of MoTER-HF

Not Applicable
Conditions
Heart Failure
Cardiovascular Disease
Cardiac Disease
Chronic Heart Failure
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12619001432101
Lead Sponsor
The Australian E-Health Research Center, CSIRO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
54
Inclusion Criteria

Patients diagnosed with HF, able to read and write in English, and interested in Information Technology (IT) and smart phone based interventions.

Exclusion Criteria

Potential participants are excluded if they were unable to participate in virtual clinic due to medical care needs, unable to operate a Smartphone for purposes of the trial (e.g. vision, hearing, cognitive or dexterity impairment), had no experience with mobile/smartphones, or were involved in another trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is patients' uptake to the smartphone based intervention.<br>Patient’s uptake is scored based on the pattern developed for patients’ uptake to clinical interventions. The score of uptake is identified using a table from the book Riekert, K. A. (2006). Promoting Treatment Adherence: A Practical Handbook for Health Care Providers Integrating Regimen Adherence Assessment into Clinical Practice.: Sage Publication.[3 months post baseline assessment];The primary outcome is patients' adherence to the smartphone based intervention. Patient’s adherence is scored based on the pattern developed for patients’ adherence to clinical interventions.The score of adherence is identified using a table from the book Riekert, K. A. (2006). Promoting Treatment Adherence: A Practical Handbook for Health Care Providers Integrating Regimen Adherence Assessment into Clinical Practice.: Sage Publication.<br>[3 months post baseline assessment]
Secondary Outcome Measures
NameTimeMethod
Quality of life measured by European Quality of Life-5 Dimensions (EQ-5D).[3 months post baseline assessment];self-efficacy measured by self-efficacy for managing chronic disease 6 item scale.<br>[3 months post baseline assessment];Body weight measured by patient and send through Bluetooth enabled weight scale. <br>[3 months post baseline assessment];Depression, anxiety and stress will be measured with DASS21.<br>[3 months post baseline assessment];Heart Failure Knowledge will be assessed by the Dutch Heart Failure Knowledge Questionnaire. [3 months post baseline assessment]
© Copyright 2025. All Rights Reserved by MedPath